Glenmark, Sun Pharma, Zydus recall medicines in US Over Mfg Issues

New Delhi: Indian drug makers Glenmark Pharmaceuticals, Sun Pharmaceutical Industries, and Zydus are recalling several medicines from the US market due to manufacturing-related problems, according to a latest report by the US Food and Drug Administration (FDA).

Mumbai-based Glenmark is recalling over 25 products from the US due to deviations from current good manufacturing practices (CGMP).

Its US arm, Glenmark Pharmaceuticals Inc., based in New Jersey, is pulling back several medicines, including Propafenone Hydrochloride extended-release capsules and Solifenacin Succinate Tablets.